Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2016 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.
N Engl J Med. 2016.
PMID: 27295427
Free PMC article.
Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.
Mann JFE, et al.
N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.
N Engl J Med. 2017.
PMID: 28854085
Free article.
Clinical Trial.
Item in Clipboard
Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
Marx PF, Havik SR, Bouma BN, Meijers JC.
Marx PF, et al.
J Thromb Haemost. 2005 Jun;3(6):1293-300. doi: 10.1111/j.1538-7836.2005.01322.x.
J Thromb Haemost. 2005.
PMID: 15946220
Free article.
Understanding the molecular mechanisms of TAFIa inactivation will allow the development of compounds that modulate TAFIa activity. Based on their three-dimensional model of TAFI, Barbosa Pereira et al. [J Mol Biol (2002), vol. 321, pp. 537-547] suggested that Ile182 and Il …
Understanding the molecular mechanisms of TAFIa inactivation will allow the development of compounds that modulate TAFIa activity. Based on …
Item in Clipboard
Cite
Cite